# Paul Workman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-workman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,544 |
| Field | Heat shock proteins research |
| h-index | 106 |
| i10-index | 470 |
| Last Known Institution | Institute of Cancer Research |
| OpenAlex ID | https://openalex.org/A5003965204 |
| ORCID iD | https://orcid.org/0000-0003-1659-3034 |
| Works | 1,179 |

## Researcher papers

- [Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies](https://scholariq.org/papers/phase-i-pharmacokinetic-and-pharmacodynamic-study-of-17-allylamino-17/)
- [First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors](https://scholariq.org/papers/first-in-human-phase-i-study-of-pictilisib-gdc-0941-a-potent-pan-class-i/)

## Researcher topics

- [Heat shock proteins research](https://scholariq.org/topics/heat-shock-proteins-research/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

## Researcher university

- [Institute of Cancer Research](https://scholariq.org/institutions/institute-of-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.